الولايات المتحدة · منصات وبيانات · Finviz

Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026

نشره Finviz · الولايات المتحدة منذ 3 ي

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially…

اقرأ المقال كاملًا على Finviz سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (finviz.com)

يستحق القراءة أيضًا

Seeking Alpha

Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Binders

Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026

مشاركة

يستحق القراءة أيضًا

Tech stocks weigh on Nasdaq for second week; Roper leads gainers

Split $5,000 Across These 5 Dividend Stocks and Don't Look Until 2031

I want to pay off $4,500 in credit-card debt in 2 months. Is this possible?

After previous day’s slump, trading is quieter among AI shares

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Binders